PAM
AMPH icon

Princeton Alpha Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Princeton Alpha Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-10,299
Closed -$195K – 687
2016
Q3 		$195K Buy
+10,299
New +$187K 0.04% 659

Other funds holding AMPH

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Princeton Alpha Management's AMPH Position: Q4 2016 in Review

Princeton Alpha Management sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2016, closing a stake of 10,299 shares — an estimated $195K sold.

Princeton Alpha Management first reported a position in AMPH in Q3 2016 and held it in 1 quarter. The position peaked at $195K in Q3 2016. 138 funds tracked by Wall St. Rank hold AMPH as of Q4 2016.

  • Princeton Alpha Management reported no remaining Amphastar Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Princeton Alpha Management sold 10,299 Amphastar Pharmaceuticals shares in Q4 2016, an estimated $195K.
  • Princeton Alpha Management first reported a position in Amphastar Pharmaceuticals in Q3 2016 and held it in 1 quarter.
  • Princeton Alpha Management's Amphastar Pharmaceuticals position peaked at $195K in Q3 2016.
  • 138 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2016.

Based on Princeton Alpha Management's 13F filing for Q4 2016, filed 10 Feb 2017.